← Back to Patent Explorer
US4876335A Expired / Lapsed US ⏱️ 0.0 years remaining

Poly-labelled oligonucleotide derivative

Assignee: Wakunaga Pharmaceutical Co Ltd
•
Filing: 1987-06-30
•
Granted: 1989-10-24
•
Expires: 2007-06-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A poly-labelled oligonucleotide having a plurality of labels, comprising labels carried on a polylysine and having the polylysine introduced on the extension from 5'- and/or 3'-end through phosphate group is useful as a probe for hybridization.

Inventors

  • 👤 Akio Yamane
  • 👤 Tatsuro Kawasoe
  • 👤 Noriko Tsukumo
  • 👤 Kenichi Miyoshi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 16:45
CPC Classifications
C; C07; C07H; C07H21/00; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6876; C12Q1/6888; C12Q1/689

Claims Analysis

Total Claims: 22
Claim 1
Independent Claim 241 words
A poly-labelled oligonucleotide derivative represented by the following formula [I]: ##STR5## wherein: either one of R 1 and R 2 is a group represented by the formula [II] shown below and the other is a hydrogen atom or a phosphate group, or both of R 1 and R 2 are groups represented by the formula [II] shown below; n is a natural number from 6 to 200; and B is nucleotide base selected from the group consisting of adenine, thymine, cytosine and guanine; ##STR6## wherein: a is a natural number from 2 to 50 and b is a natural number from 1 to 50, with b+1≧a; R 3 is an alkylene group having 2 to 20 carbon atoms; X represents an oxygen atom or an imino group; (Lys) b represents a lysine moiety when b=1 and a polylysine moiety when b=2 to 50, wherein said polylysine is a polymerization product of lysine through the reaction of its amino group and its carboxylic group with the number of molecules of lysine polymerized therein being equal to b, and wherein (Lys) b is bonded to the moiety --NH-- in formula [II] through reaction of the carboxylic group in the (Lys) b moiety; Y is a label which is selected from the group consisting of biotin, haptens, fluorophores, and chemiluminescent substances, and which is covalently bonded to the (Lys) b moiety through reaction with the amino group or groups in the (Lys) b moiety.
Claim 2
Dependent Claim 241 words
A poly-labelled oligonucleotide derivative represented by the following formula [I]: ##STR5## wherein: either one of R 1 and R 2 is a group represented by the formula [II] shown below and the other is a hydrogen atom or a phosphate group, or both of R 1 and R 2 are groups represented by the formula [II] shown below; n is a natural number from 6 to 200; and B is nucleotide base selected from the group consisting of adenine, thymine, cytosine and guanine; ##STR6## wherein: a is a natural number from 2 to 50 and b is a natural number from 1 to 50, with b+1≧a; R 3 is an alkylene group having 2 to 20 carbon atoms; X represents an oxygen atom or an imino group; (Lys) b represents a lysine moiety when b=1 and a polylysine moiety when b=2 to 50, wherein said polylysine is a polymerization product of lysine through the reaction of its amino group and its carboxylic group with the number of molecules of lysine polymerized therein being equal to b, and wherein (Lys) b is bonded to the moiety --NH-- in formula [II] through reaction of the carboxylic group in the (Lys) b moiety; Y is a label which is selected from the group consisting of biotin, haptens, fluorophores, and chemiluminescent substances, and which is covalently bonded to the (Lys) b moiety through reaction with the amino group or groups in the (Lys) b moiety.
Claim 3
Dependent Claim 13 words
A poly-labelled oligonucleotide according to claim 1, wherein n is 10 to 60.
Claim 4
Dependent Claim 13 words
A poly-labelled oligonucleotide according to claim 2, wherein n is 15 to 40.
Claim 5
Dependent Claim 13 words
A poly-labelled oligonucleotide according to claim 1, wherein a is 2 to 21.
Claim 6
Dependent Claim 13 words
A poly-labelled oligonucleotide according to claim 4, wherein a is 2 to 11.
Claim 7
Dependent Claim 13 words
A poly-labelled oligonucleotide according to claim 1, wherein b is 1 to 20.
Claim 8
Dependent Claim 13 words
A poly-labelled oligonucleotide according to claim 6, wherein b is 1 to 10.
Claim 9
Dependent Claim 13 words
A poly-labelled oligonucleotide according to claim 1, wherein b is at least 2.
Claim 10
Dependent Claim 21 words
A poly-labelled oligonucleotide according to claim 1, wherein both of R 1 and R 2 are represented by the formula [II].
Claim 11
Dependent Claim 29 words
A poly-labelled oligonucleotide according to claim 1, wherein one of R 1 and R 2 is a group represented by the formula [II] and the other is hydrogen atom.
Claim 12
Dependent Claim 28 words
A poly-labelled oligonucleotide according to claim 1, wherein one of R 1 and R 2 is a group represented by the formula [II] and the other is phosphate.
Claim 13
Dependent Claim 12 words
A poly-labelled oligonucleotide according to claim 1, wherein X is oxygen atom.
Claim 14
Dependent Claim 12 words
A poly-labelled oligonucleotide according to claim 1, wherein X is imino group.
Claim 15
Dependent Claim 20 words
A poly-labelled oligonucleotide according to claim 1, wherein R 3 is an alkylene group having 2 to 6 carbon atoms.
Claim 16
Dependent Claim 11 words
A poly-labelled oligonucleotide according to claim 1, wherein Y is biotin.
Claim 17
Dependent Claim 12 words
A poly-labelled oligonucleotide according to claim 1, wherein Y is 2,4-dinitrophenyl group.
Claim 18
Dependent Claim 11 words
A poly-labelled oligonucleotide according to claim 1, wherein Y is fluoresceine.
Claim 19
Dependent Claim 11 words
A poly-labelled oligonucleotide according to claim 1, wherein Y is rhodamine.
Claim 20
Dependent Claim 16 words
A poly-labelled oligonucleotide according to claim 18, wherein Y is a compound of the formula: ##STR7##
Claim 21
Dependent Claim 11 words
A poly-labelled oligonucleotide according to claim 1, wherein Y is 7-nitrobenzofurazane.
Claim 22
Dependent Claim 11 words
A poly-labelled oligonucleotide according to claim 1, wherein Y is dansyl.

References Cited (Backward Citations)

US4605735A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-10-23 1993-04-24 1993-10-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-10-23 1997-04-24 1997-10-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-10-23 2001-04-24 2001-10-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag